利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

9 条记录 (耗时 0.013 秒)

    NOVEL PYRIMIDINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION INCLUDING SAME AS AN ACTIVE INGREDIENT
    1.
    发明申请
    NOVEL PYRIMIDINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION INCLUDING SAME AS AN ACTIVE INGREDIENT 审中-公开
    新型吡咯烷衍生物和药物组合物，包括作为活性成分的组合物

    公开(公告)号：US20140163226A1

    公开(公告)日：2014-06-12

    申请号：US14232667

    申请日：2012-06-29

    申请人： Chul Hyun Park ,  Won Jeoung Kim ,  Young Hee Jung ,  Nam Du Kim ,  Young Kil Chang ,  Maeng Sup Kim

    发明人： Chul Hyun Park ,  Won Jeoung Kim ,  Young Hee Jung ,  Nam Du Kim ,  Young Kil Chang ,  Maeng Sup Kim

    IPC分类号： C07D495/04 ,  C07D487/04

    CPC分类号： C07D495/04 ,  C07D487/04

    摘要： The present invention relates to a compound represented by formula (I) for inhibiting the activity of diacylglycerol O-acyltransferase type 1 (DGAT1), and pharmaceutically acceptable salts thereof, and a pharmaceutical composition comprising same as an active ingredient. The compound of the present invention may be used effectively in the treatment or prevention of a disease or condition mediated by the activity of DGAT1 such as obesity, type II diabetes, dyslipidemia, metabolic syndrome, and the like, without any adverse effects: wherein A, B, X, and R5 to R7 are the same as defined in the specification.

    摘要翻译： 本发明涉及一种抑制二酰基甘油O-酰基转移酶1型（DGAT1）的活性的式（I）表示的化合物及其药学上可接受的盐，以及含有该活性成分的药物组合物。 本发明的化合物可以有效地用于治疗或预防由诸如肥胖，II型糖尿病，血脂异常，代谢综合征等的DGAT1的活性介导的疾病或病症，而没有任何不利影响：其中A ，B，X和R5至R7与说明书中所定义相同。

    PROCESS FOR PREPARING BEPOTASTINE AND INTERMEDIATES USED THEREIN
    3.
    发明申请
    PROCESS FOR PREPARING BEPOTASTINE AND INTERMEDIATES USED THEREIN 审中-公开
    用于制备BEPOTASTINE及其中间体的方法

    公开(公告)号：US20100168433A1

    公开(公告)日：2010-07-01

    申请号：US12663983

    申请日：2008-06-05

    申请人： Tae Hee Ha ,  Chang Hee Park ,  Won Jeoung Kim ,  Soohwa Cho ,  Han Kyong Kim ,  Kwee Hyun Suh

    发明人： Tae Hee Ha ,  Chang Hee Park ,  Won Jeoung Kim ,  Soohwa Cho ,  Han Kyong Kim ,  Kwee Hyun Suh

    IPC分类号： C07D401/12

    CPC分类号： C07D401/12

    摘要： A process for stereospecific preparation of bepotastine of formula (I) and novel intermediates used therein having formulae (II) to (IV) are provided. The inventive process comprises subjecting (RS)-4-[(4-chlorophenyl)(2-pyridyl)methoxy]piperidine to a reaction with a 4-halobutanoic acid l-menthyl ester, halo being chloro, bromo or iodo, in an organic solvent in the presence of a base to produce (RS)-bepotastine l-menthyl ester of formula (II), conducting a reaction of the compound of formula (II) with N-benzyloxycarbonyl L-aspartic acid in an organic solvent to induce selective precipitation of bepotastine l-menthyl ester.N-benzyloxycarbonyl L-aspartate of formula (III), filtering the precipitates formed in step 2) to isolate the compound of formula (III), treating the compound of formula (III) with a base to liberate bepotastine l-menthyl ester of formula (IV), and hydrolyzing the compound of formula (IV) in the presence of a base. The inventive process can provide bepotastine having a high optical purity of not less than 99.5% in a high yield, and thus, is useful in the development of anti-histamines and anti-allergic agents.

    摘要翻译： 提供了式（I）的贝他辛汀的立体特异性制备方法和其中使用的具有式（II）至（IV）的新型中间体。 本发明的方法包括使（RS）-4 - [（4-氯苯基）（2-吡啶基）甲氧基]哌啶与4-卤代丁酸1-薄荷酯，卤素为氯，溴或碘的有机反应 溶剂在碱的存在下反应以制备式（II）的（RS） - 贝斯塔司汀l-薄荷酯，在有机溶剂中进行式（II）化合物与N-苄氧基羰基L-天冬氨酸的反应，以诱导选择性 贝他辛汀1-薄荷酯的沉淀。式（III）的N-苄氧基羰基L-天冬氨酸盐，过滤步骤2）中形成的沉淀物以分离式（III）化合物，用碱将式（III）化合物 释放式（IV）的布他辛酯l-薄荷酯，并在碱的存在下水解式（IV）的化合物。 本发明方法可以以高产率提供具有不低于99.5％的高光学纯度的贝他斯汀，因此可用于抗组胺和抗过敏剂的开发。